In a murine model of lung adenocarcinoma, B cells were found to promote tumor-specific CD4+Tfh cell differentiation, which then produced IL-21 to enhance CD8+T cell responses to drive anti-tumor immunity (18). This evidence concerns the gene CD8A and neoplasm.